Cgrel Tablet 10's
₹66.44*
MRP ₹75.5
12% off
₹64.5*
MRP ₹75.5
15% CB
₹11 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Cgrel Tablet is used for the prevention of heart attack or stroke in people at high risk of heart disease. A heart attack generally refers to the blocked flow of blood to the heart because of the blockage of arteries. A heart blockage is most often a build-up of fat, cholesterol and other substances, which form a plaque in the arteries that feed the heart (coronary arteries).
Cgrel Tablet belongs to a class of medications called a blood thinner or an antiplatelet medication. Cgrel Tablet plays a vital role in preventing the formation of harmful blood clots (plaque) in your veins. It makes your blood flow easily through your veins, making it less likely to form a serious blood clot. So, an intake of Cgrel Tablet helps prevent blood clots if you have an increased risk of having severe chest pain (unstable angina or heart attack), stroke, or peripheral arterial disease (heart problem due to narrowed blood vessels).
The recommended daily dose of Cgrel Tablet is 75 mg once daily orally, with or without food. It should be swallowed whole with a glass of water. Do not chew, bite or break it. Your doctor will advise you how often you take your tablets based on your medical condition. In some cases, you may experience nosebleeds, heavier periods, bleeding gums, easy bruising, diarrhoea, stomach pain, indigestion, or heartburn. If the side effects are persistent, reach out to your doctor.
Try not to stop taking this medicine of your own. Stopping a sudden intake of Cgrel Tablet may worsen your condition and increase your risk of cardiovascular death, heart attack, and stroke. Let your doctor know if you have any liver, kidney, or heart problems. Cgrel Tablet should be taken cautiously in pregnant or breastfeeding women. It should be not given to people with a bleeding disorder (haemophilia), active pathological bleeding, like a peptic ulcer, or bleeding in the brain (intracranial haemorrhage). Do not take Cgrel Tablet with aspirin or ibuprofen for pain relief while you are using Cgrel Tablet . It may increase the chance of having stomach ulcers or severe gastric bleeding.
Cgrel Tablet plays a vital role in preventing the formation of harmful blood clots in your blood vessels by making platelets (clotting agents) stick together. Thus, it helps to reduce the risk of heart attack, stroke, unstable angina (heart-related chest pain), and peripheral arterial disease (blocked or poor blood flow due to narrowed blood vessels) in heart disease patients and patients who have undergone recent heart surgery with a stent.
Indigestion medicines known as proton pump inhibitors like omeprazole should be used with caution while taking Cgrel Tablet . Prolonged use of Cgrel Tablet can cause bleeding problems (like nosebleeds, heavier periods, bleeding gums, and easy bruising). If you are going to have any surgery, discontinue taking Cgrel Tablet 5 days before the surgery. Discontinuation of Cgrel Tablet might increase the risk of heart attack, stroke, and other risks of cardiovascular events. So, do not stop taking Cgrel Tablet suddenly. If you have had a recent stroke or heart attack, stop the intake of Cgrel Tablet with painkillers like aspirin or ibuprofen, as it can increase your stomach or gastrointestinal bleeding. Purpura (blood leakage under the skin) has been observed with the use of Cgrel Tablet , including in fatal cases.
Drug-Drug Interactions: Cgrel Tablet may have interaction with other anticoagulants (e.g. warfarin, aspirin, rivaroxaban, apixaban), pain killers (e.g. ibuprofen), antidepressants (e.g. citalopram), and indigestion medicine/proton pump inhibitors (e.g. omeprazole).
Drug-Food Interactions: Cgrel Tablet may interact with Ginkgo biloba and St John’s wort plant (used as an antidepressant) and increase the risk of bleeding.
Drug-Disease Interactions: Cgrel Tablet should not be given to the people with stomach ulcers, brain haemorrhage (bleeding in your brain), haemophilia (a bleeding disorder), and liver or kidney problems.
A blood clot can occur in any part of the body and can lead to a heart attack, stroke, and damage to organs (even coma or death). Blood clots can reach your arteries or veins in organs like the brain, kidney, heart, lungs, and limbs. Conditions like atherosclerosis, diabetes, heart failure, irregular heartbeat (arrhythmia), and obesity/overweight can trigger excessive blood clotting in the brain and heart. On the other hand, deep vein thrombosis (blood clot in veins), peripheral artery disease (narrowed arteries due to fat deposit or blood clot), and atherosclerosis (fat built upon the walls of the arteries) can cause a blood clot in your limbs.
Alcohol
Caution
You can drink alcohol with Cgrel Tablet . But do not drink too much while taking this medicine. It can irritate your stomach.
Pregnancy
Caution
Cgrel Tablet should not be taken until prescribed. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast Feeding
Caution
Cgrel Tablet should not be taken until prescribed. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Driving
Safe if prescribed
Cgrel Tablet has no or negligible influence on the ability to drive or use machines.
Liver
Safe if prescribed
No dosage adjustment is necessary in patients with liver disease.
Kidney
Caution
Cgrel Tablet should be taken with caution, especially if you have a history of Kidney diseases/conditions. Your doctor may have to adjust the dose.
Children
Unsafe
Cgrel Tablet is not recommended for children. The safety and effectiveness of Cgrel Tablet have not been established in children due to limited testing of this drug on children by competent authorities across the world.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes